1. Home
  2. UTG vs LGND Comparison

UTG vs LGND Comparison

Compare UTG & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UTG

Reaves Utility Income Fund of Beneficial Interest

HOLD

Current Price

$36.67

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$198.41

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTG
LGND
Founded
2003
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.9B
IPO Year
N/A
1992

Fundamental Metrics

Financial Performance
Metric
UTG
LGND
Price
$36.67
$198.41
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$239.33
AVG Volume (30 Days)
317.8K
223.2K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
7.28%
N/A
EPS Growth
N/A
0.76
EPS
9.86
2.49
Revenue
$96,107,593.00
$251,233,000.00
Revenue This Year
N/A
$52.87
Revenue Next Year
N/A
$6.07
P/E Ratio
$3.20
$79.16
Revenue Growth
8.35
64.83
52 Week Low
$25.26
$93.58
52 Week High
$35.29
$212.49

Technical Indicators

Market Signals
Indicator
UTG
LGND
Relative Strength Index (RSI) 46.00 56.71
Support Level $35.87 $194.44
Resistance Level $36.99 $202.97
Average True Range (ATR) 0.57 5.93
MACD 0.01 0.84
Stochastic Oscillator 47.25 81.22

Price Performance

Historical Comparison
UTG
LGND

About UTG Reaves Utility Income Fund of Beneficial Interest

Reaves Utility Income Fund is a closed-end management investment company. The company's investment objective is to provide a high level of after-tax income and total return consisting of tax-advantaged dividend income and capital appreciation. It invests a portion of its total assets in securities of utility companies, which may include companies in the electric, gas, water, telecommunications sectors, as well as other companies engaged in other infrastructure operations.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: